Evidence map›Paper›PMID 31878275›Full record

ArticleBiomolecules2019

Cell Membrane-Interrupting Antimicrobial Peptides from

Jia Wu, Hafiz Muhammad Khalid Abbas, Jiale Li, Yuan Yuan, Yunjun Liu, Guoying Wang, And Wubei Dong

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A novel antimicrobial peptide screened by aFrontiers in immunology · 2023
    Article
  5. Isolation of Potato Endophytes and Screening ofInternational journal of molecular sciences · 2022
    Article
  6. Article
  7. Biocontrol potential ofFrontiers in microbiology · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Isolation of Antimicrobial Genes fromInternational journal of molecular sciences · 2020
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jia WuDepartment of Plant Pathology, College of Plant Science and Technology and the Key Lab of Crop Disease Monitoring & Safety Control in Hubei Province, Huazhong Agricultural University, 430070 Wuhan, Hubei Province, China.
Hafiz Muhammad Khalid AbbasVegetable Research Institute, Guangdong Academy of Agricultural Sciences, Guangzhou 510640, China.
Jiale LiDepartment of Plant Pathology, College of Plant Science and Technology and the Key Lab of Crop Disease Monitoring & Safety Control in Hubei Province, Huazhong Agricultural University, 430070 Wuhan, Hubei Province, China.
Yuan YuanNational Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Yunjun LiuInstitute of Crop Science, Chinese Academy of Agricultural Sciences, South Street of Zhongguancun 12, Beijing 100081, China.
Guoying WangInstitute of Crop Science, Chinese Academy of Agricultural Sciences, South Street of Zhongguancun 12, Beijing 100081, China.
And Wubei DongDepartment of Plant Pathology, College of Plant Science and Technology and the Key Lab of Crop Disease Monitoring & Safety Control in Hubei Province, Huazhong Agricultural University, 430070 Wuhan, Hubei Province, China.
Huazhong Agricultural University · CNChinese Academy of Agricultural Sciences · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNGuangdong Academy of Agricultural Sciences · CN

Funding

HSRD VA TPP 10-008
6 · The paper itself

Abstract

The situation of drug resistance has become more complicated due to the scarcity of plant resistance genes, and overcoming this challenge is imperative. Isatis indigotica has been used for the treatment of wounds, viral infections, and inflammation for centuries. Antimicrobial peptides (AMPs) are found in all classes of life ranging from prokaryotes to eukaryotes. To identify AMPs, I. indigotica was explored using a novel, sensitive, and high-throughput Bacillus subtilis screening system. We found that IiR515 and IiR915 exhibited significant antimicrobial activities against a variety of bacterial (Xanthomonas oryzae, Ralstonia solanacearum, Clavibacter michiganensis, and C. fangii) and fungal (Phytophthora capsici and Botrytis cinerea) pathogens. Scanning electron microscope and cytometric analysis revealed the possible mechanism of these peptides, which was to target and disrupt the bacterial cell membrane. This model was also supported by membrane fluidity and electrical potential analyses. Hemolytic activity assays revealed that these peptides may act as a potential source for clinical medicine development. In conclusion, the plant-derived novel AMPs IiR515 and IiR915 are effective biocontrol agents and can be used as raw materials in the drug discovery field.

Indexed as

Antimicrobial Cationic PeptidesBacillus subtilisBiotechnologyCell MembraneGene ExpressionIsatisNicotianaPeptidesAntimicrobial Cationic PeptidesPeptidesantimicrobial peptideBacillus subtilisgene expression systemIsatis indigoticamembrane-interrupting peptidesplant resistance gene

Identifiers

PMID31878275
PMCPMC7023251
OpenAlexW2997581319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.